Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3220548
Max Phase: Preclinical
Molecular Formula: C18H10F4N2O2
Molecular Weight: 362.28
Molecule Type: Small molecule
Associated Items:
ID: ALA3220548
Max Phase: Preclinical
Molecular Formula: C18H10F4N2O2
Molecular Weight: 362.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cccc1F
Standard InChI: InChI=1S/C18H10F4N2O2/c19-9-4-5-10(14(22)8-9)17(26)11-6-7-15(25)24(18(11)23)16-12(20)2-1-3-13(16)21/h1-8H,23H2
Standard InChI Key: SDWCOPUSJBCAAX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 362.28 | Molecular Weight (Monoisotopic): 362.0678 | AlogP: 3.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 65.09 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.16 | CX LogD: 3.16 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.57 | Np Likeness Score: -1.06 |
1. Charlton MH, Brotherton DH, Owen J, Clark VL, Testar RJ, Davies SJ, Moffat DFC. (2012) Monocyte and macrophage selective anti-inflammatory kinase inhibitors, 3 (9): [10.1039/C2MD20158E] |
Source(1):